Tech Company Financing Transactions
NuCicer Funding Round
Leaps by Bayer and private investors participated in a $7 million Seed capital raise for NuCicer. This venture round was announced on 11/3/2022.
Transaction Overview
Company Name
Announced On
11/3/2022
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
Leaps by Bayer (Lead Investor)
Proceeds Purpose
The seed funding will go toward manufacturing costs associated with commercial production of the protein-heavy chickpeas.
Company Information
Company Status
Private & Independent
Industry
RetailTech
Mailing Address
28605 County Rd. 104
Davis, CA 95618
USA
Davis, CA 95618
USA
Phone
Undisclosed
Website
Email Address
Overview
NuCicer's proprietary, non-GM chickpeas with dramatically increased protein content cut the cost of production for chickpea protein nearly in half, transforming opportunities for food and beverage products. NuCicer's technology stems from twenty years of world-class legume genetics research and chickpea breeding led by Professor Douglas Cook, Co-Founder and CSO at NuCicer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kathryn Cook
Browse more venture capital transactions:
Prev: 11/3/2022: Oro venture capital transaction
Next: 11/3/2022: Meez venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs